The increasing occurrences of polyps and inflammatory bowel conditions like ulcerative colitis or Crohn’s disease are primarily propelling the colorectal cancer market.

1. Colorectal Cancer
Market Research
Report 2023-2033

2. ABOUT IMARC
2
International Market Analysis Research and Consulting Group is a
leading adviser on management strategy and market research
worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific,
economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations.
Market forecasts and industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel and tourism,
nanotechnology and novel processing methods are at the top of
the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into
the dynamics of companies and markets with close cooperation at
all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient
organizations, and secure lasting results.

3. Report Description and Highlights
Colorectal Cancer Market 2023-2033
The newly published report by IMARC Group, titled ”Colorectal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth,
Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the colorectal cancer market. The report provides an overview
of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview,
market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and recent advancements in the
seven major markets (7MM). The report also highlights key segments and market drivers, as well as challenges faced by industry players.
3

4. Report Description and Highlights
What is colorectal cancer?
Colorectal cancer, emerging from either the colon or rectum, typically starts as polyps within these organs. Symptoms often include
persistent changes in bowel habits, rectal bleeding, abdominal discomfort, and unanticipated weight loss. Continual fatigue, abdominal
lumps, and a reduced red blood cell count may also occur.
Diagnosis involves a variety of tests, such as rectal exams, colonoscopy, sigmoidoscopy, biopsy, stool DNA tests, CT colonography, and
several imaging tests like CT scans, MRIs, and barium enema X-rays. Depending on the individual case, treatments may comprise surgery,
chemotherapy, radiation therapy, or a blend of these therapies.
Request a Sample Report: https://www.imarcgroup.com/colorectal-cancer-market/requestsample
4

5. Report Description and Highlights
What are the key drivers and trends in the colorectal cancer market?
The increasing occurrences of polyps and inflammatory bowel conditions like ulcerative colitis or Crohn’s disease are primarily propelling
the colorectal cancer market. The market is further supported by the growing incidence of risk factors, such as alcohol use, smoking, and
diets rich in red or processed meats, which heighten the chances of colorectal cancer. Enhanced awareness about early detection and
improving survival rates are positively influencing the market, with several screening tests like stool-based tests and virtual colonoscopies
aiding timely discovery.
The broad acceptance of combination therapies to enhance treatment results and lower cancer recurrence also fuels market growth. The
rising trend of precision medicine, which provides personalized regimens based on a patient’s tumor genetics for targeted and effective
therapy, is another market driver. The escalating interest in complementary and alternative therapies, such as acupuncture and herbal
medications, for managing treatment side effects and improving overall health is also predicted to stimulate the colorectal cancer market in
the future.
5

6. Report Description and Highlights
What is included in the report segmentation?
The report covers the following aspects:
Report Period:
• Base Year: 2022
• Historical Period: 2017-2022
• Market Forecast: 2023-2033
Countries Included:
• United States
• Germany
• France
6

7. Report Description and Highlights
• United Kingdom
• Italy
• Spain
• Japan
Analysis Covered Across Each Country
• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the Colorectal Cancer market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the Colorectal Cancer market
• Reimbursement scenario in the market
• In-market and pipeline drugs
7

8. Report Description and Highlights
In-Market Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Regulatory Status
View Report TOC, Figures and Tables: https://www.imarcgroup.com/colorectal-cancer-market
8

9. Key Questions Answered in the Report
1. How has the Colorectal Cancer market performed so far and how will it perform in the coming years?
2. What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
3. What was the country-wise size of the Colorectal Cancer market across the seven major markets in 2022 and what will it look like in
2033?
4. What is the growth rate of the Colorectal Cancer market across the seven major markets and what will be the expected growth over
the next ten years?
5. What are the key unmet needs in the market?
9

10. Table of
Contents

11. Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Colorectal Cancer - Introduction
11

12. Table of Contents
4.1 Overview
4.2 Regulatory Process
4.3 Epidemiology (2017-2022) and Forecast (2023-2033)
4.4 Market Overview (2017-2022) and Forecast (2023-2033)
4.5 Competitive Intelligence
5 Colorectal Cancer - Disease Overview
5.1 Introduction
5.2 Symptoms and Diagnosis
5.3 Pathophysiology
5.4 Causes and Risk Factors
5.5 Treatment
Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/colorectal-cancer-
market/toc
12

13. Partial List Of Our Clients
13

14. OUR CLIENTS
14

15. Disclaimer
15
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis
Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or
in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including
photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information
and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting
makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts
no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and
Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.